Zheng Y, Thomas A, Schmidt C M, Dann C T
Indiana University, 800 E. Kirkwood Ave, Bloomington, IN 47405-7102, USA.
Indiana University, 800 E. Kirkwood Ave, Bloomington, IN 47405-7102, USA
Hum Reprod. 2014 Nov;29(11):2497-511. doi: 10.1093/humrep/deu232. Epub 2014 Sep 29.
Can human spermatogonia be detected in long-term primary testicular cell cultures using validated, germ cell-specific markers of spermatogonia?
Germ cell-specific markers of spermatogonia/spermatogonial stem cells (SSCs) are detected in early (1-2 weeks) but not late (> 6 weeks) primary testicular cell cultures; somatic cell markers are detected in late primary testicular cell cultures.
The development of conditions for human SSC culture is critically dependent on the ability to define cell types unequivocally and to quantify spermatogonia/SSCs. Growth by somatic cells presents a major challenge in the establishment of SSC cultures and therefore markers that define spermatogonia/SSCs, but are not also expressed by testicular somatic cells, are essential for accurate characterization of SSC cultures.
STUDY DESIGN, SIZE, DURATION: Testicular tissue from eight organ donors with normal spermatogenesis was used for assay validation and establishing primary testicular cell cultures.
PARTICIPANTS/MATERIALS, SETTING, METHODS: Immunofluorescence analysis of normal human testicular tissue was used to validate antibodies (UTF1, SALL4, DAZL and VIM) and then the antibodies were used to demonstrate that primary testicular cells cultured in vitro for 1-2 weeks were composed of somatic cells and rare germ cells. Primary testicular cell cultures were further characterized by comparing to testicular somatic cell cultures using quantitative reverse transcriptase PCR (UTF1, FGFR3, ZBTB16, GPR125, DAZL, GATA4 and VIM) and flow cytometry (CD9 and SSEA4).
UTF1, FGFR3, DAZL and ZBTB16 qRT-PCR and SSEA4 flow cytometry were validated for the sensitive, quantitative and specific detection of germ cells. In contrast, GPR125 mRNA and CD9 were found to be not specific to germ cells because they were also expressed in testicular somatic cell cultures. While the germ cell-specific markers were detected in early primary testicular cell cultures (1-2 weeks), their expression steadily declined over time in vitro. After 6 weeks in culture only somatic cells were detected.
LIMITATIONS, REASONS FOR CAUTION: Different groups attempting SSC culture have utilized different sources of human testes and minor differences in the preparation and maintenance of the testicular cell cultures. Differences in outcome may be explained by genetic background of the source tissue or technical differences.
The ability to propagate human SSCs in vitro is a prerequisite for proposed autologous transplantation therapy aimed at restoring fertility to men who have been treated for childhood cancer. By applying the assays validated here it will be possible to quantitatively compare human SSC culture conditions. The eventual development of conditions for long-term propagation of human SSCs in vitro will greatly facilitate learning about the basic biology of these cells and in turn the ability to use human SSCs in therapy.
STUDY FUNDING/COMPETING INTERESTS: The experiments presented in this manuscript were funded by a Project Development Team within the ICTSI NIH/NCRR Grant Number TR000006. The authors declare no competing interests.
Not applicable.
能否使用经过验证的精原细胞特异性标志物,在长期原代睾丸细胞培养物中检测到人类精原细胞?
在早期(1 - 2周)而非晚期(> 6周)的原代睾丸细胞培养物中检测到了精原细胞/精原干细胞(SSCs)的生殖细胞特异性标志物;在晚期原代睾丸细胞培养物中检测到了体细胞标志物。
人类SSC培养条件的发展严重依赖于明确界定细胞类型以及定量精原细胞/SSCs的能力。体细胞的生长是建立SSC培养物的一个主要挑战,因此,能够界定精原细胞/SSCs但睾丸体细胞不表达的标志物,对于准确鉴定SSC培养物至关重要。
研究设计、规模、持续时间:来自八名精子发生正常的器官捐赠者的睾丸组织用于分析验证和建立原代睾丸细胞培养物。
参与者/材料、设置、方法:使用正常人睾丸组织的免疫荧光分析来验证抗体(UTF1、SALL4、DAZL和VIM),然后使用这些抗体来证明体外培养1 - 2周的原代睾丸细胞由体细胞和罕见的生殖细胞组成。通过定量逆转录PCR(UTF1、FGFR3、ZBTB16、GPR125、DAZL、GATA4和VIM)和流式细胞术(CD9和SSEA4)与睾丸体细胞培养物进行比较,对原代睾丸细胞培养物进行进一步表征。
UTF1、FGFR3、DAZL和ZBTB16的qRT - PCR以及SSEA4流式细胞术经过验证,可用于生殖细胞的灵敏、定量和特异性检测。相比之下,发现GPR125 mRNA和CD9并非生殖细胞特异性,因为它们在睾丸体细胞培养物中也有表达。虽然在早期原代睾丸细胞培养物(1 - 2周)中检测到了生殖细胞特异性标志物,但它们在体外培养过程中的表达随时间稳步下降。培养6周后仅检测到体细胞。
局限性、谨慎原因:不同的研究小组尝试进行SSC培养时,使用了不同来源的人类睾丸,并且在睾丸细胞培养物的制备和维持方面存在细微差异。结果的差异可能由来源组织的遗传背景或技术差异来解释。
体外扩增人类SSCs的能力是旨在恢复接受过儿童癌症治疗的男性生育能力的自体移植疗法的前提条件。通过应用此处验证的分析方法,将有可能对人类SSC培养条件进行定量比较。最终开发出人类SSCs体外长期扩增的条件将极大地促进对这些细胞基本生物学的了解,进而有助于在治疗中使用人类SSCs。
研究资金/利益冲突:本手稿中呈现的实验由ICTSI NIH/NCRR资助项目开发团队资助,资助编号为TR000006。作者声明无利益冲突。
不适用。